Glycogen synthase kinase-3 beta
Also known as: GSK3B
Function
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair (By similarity). Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF (TNF/TNFA) (By similarity). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes (By similarity). Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation (By similarity). Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibition of its activity (By similarity). Phosphorylates SIK1 at 'Thr-182', leading to sustainment of its activity. Phosphorylates ZC3HAV1 which enhances its antiviral activity. Phosphorylates SNAI1, leading to its ubiquitination and proteasomal degradation. Phosphorylates SFPQ at 'Thr-687' upon T-cell activation. Phosphorylates NR1D1 st 'Ser-55' and 'Ser-59' and stabilizes it by protecting it from proteasomal degradation. Regulates the circadian clock via phosphorylation of the major clock components including BMAL1, CLOCK and PER2. Phosphorylates FBXL2 at 'Thr-404' and primes it for ubiquitination by the SCF(FBXO3) complex and proteasomal degradation (By similarity). Phosphorylates CLOCK AT 'Ser-427' and targets it for proteasomal degradation. Phosphorylates BMAL1 at 'Ser-17' and 'Ser-21' and primes it for ubiquitination and proteasomal degradation. Phosphorylates OGT at 'Ser-3' or 'Ser-4' which positively regulates its activity. Phosphorylates MYCN in neuroblastoma cells which may promote its degradation. Regulates the circadian rhythmicity of hippocampal long-term potentiation and BMAL1 and PER2 expression (By similarity). Acts as a regulator of autophagy by mediating phosphorylation of KAT5/TIP60 under starvation conditions, activating KAT5/TIP60 acetyltransferase activity and promoting acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer. Negatively regulates extrinsic apoptotic signaling pathway via death domain receptors. Promotes the formation of an anti-apoptotic complex, made of DDX3X, BRIC2 and GSK3B, at death receptors, including TNFRSF10B. The anti-apoptotic function is most effective with weak apoptotic signals and can be overcome by stronger stimulation. Phosphorylates E2F1, promoting the interaction between E2F1 and USP11, stabilizing E2F1 and promoting its activity. Phosphorylates mTORC2 complex component RICTOR at 'Ser-1235' in response to endoplasmic stress, inhibiting mTORC2. Phosphorylates mTORC2 complex component RICTOR at 'Thr-1695' which facilitates FBXW7-mediated ubiquitination and subsequent degradation of RICTOR. Acts as a negative regulator of smoothened signaling by mediating phosphorylation of GLI2 and GLI3 in absence of smoothened, promoting their processing by the SCF(BTRC) complex. Phosphorylates FXR1, promoting FXR1 ubiquitination by the SCF(FBXO4) complex and FXR1 degradation by the proteasome (By similarity). Phosphorylates interleukin-22 receptor subunit IL22RA1, preventing its proteasomal degradation (By similarity). Phosphorylates and inhibits the CTP synthase and protein-asparagine deamidase activities of CTPS1. Phosphorylates DSP at multiple sequential serine residues in the C-terminus tail, promoting its recruitment to developing desmosome cell-cell junctions.
Classification
- Family (Pfam)
- PF00069 Pkinase
- InterPro
- GSK-3, Kinase-like_dom_sf, Prot_kinase_dom, Protein_kinase_ATP_BS, Ser/Thr_kinase_AS, STKc_GSK3
- Functional cluster
- Serine/Threonine Protein Kinases
Experimental structures · PDB · 122
- 1GNG X-ray 2.60A
- 1H8F X-ray 2.80A
- 1I09 X-ray 2.70A
- 1J1B X-ray 1.80A
- 1J1C X-ray 2.10A
- 1O6K X-ray 1.70A
- 1O6L X-ray 1.60A
- 1O9U X-ray 2.40A
- 1PYX X-ray 2.40A
- 1Q3D X-ray 2.20A
- 1Q3W X-ray 2.30A
- 1Q41 X-ray 2.10A
- … and 110 more
A predicted model is available from AlphaFold.
Gene Ontology · 107
- GO:0030424 axon
- GO:0030877 beta-catenin destruction complex
- GO:0005813 centrosome
- GO:0005737 cytoplasm
- GO:0005829 cytosol
- GO:0030425 dendrite
- GO:0005788 endoplasmic reticulum lumen
- GO:0098978 glutamatergic synapse
- GO:0005739 mitochondrion
- GO:0005654 nucleoplasm
- GO:0005634 nucleus
- GO:0005886 plasma membrane
- GO:0098794 postsynapse
- GO:0098793 presynapse
- GO:1990909 Wnt signalosome
- GO:0005524 ATP binding
- GO:0008013 beta-catenin binding
- GO:0034452 dynactin binding
- GO:0016301 kinase activity
- GO:0051059 NF-kappaB binding
- GO:0002039 p53 binding
- GO:0002020 protease binding
- GO:0034236 protein kinase A catalytic subunit binding
- GO:0004672 protein kinase activity
- GO:0019901 protein kinase binding
- GO:0106310 protein serine kinase activity
- GO:0004674 protein serine/threonine kinase activity
- GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding
- GO:0097110 scaffold protein binding
- GO:0048156 tau protein binding
- GO:0050321 tau-protein kinase activity
- GO:0031625 ubiquitin protein ligase binding
- GO:0160213 beta-arrestin-dependent dopamine receptor signaling pathway
- GO:0060070 canonical Wnt signaling pathway
- GO:0030154 cell differentiation
- GO:1904646 cellular response to amyloid-beta
- GO:0036016 cellular response to interleukin-3
- GO:0071300 cellular response to retinoic acid
- GO:0007623 circadian rhythm
- GO:0001837 epithelial to mesenchymal transition
- GO:0006983 ER overload response
- GO:0030010 establishment of cell polarity
- GO:0060079 excitatory postsynaptic potential
- GO:0097191 extrinsic apoptotic signaling pathway
- GO:0097192 extrinsic apoptotic signaling pathway in absence of ligand
- GO:0005977 glycogen metabolic process
- GO:0003170 heart valve development
- GO:0021766 hippocampus development
- GO:0008286 insulin receptor signaling pathway
- GO:0035556 intracellular signal transduction
- GO:0030011 maintenance of cell polarity
- GO:0007005 mitochondrion organization
- GO:0043066 negative regulation of apoptotic process
- GO:0070885 negative regulation of calcineurin-NFAT signaling cascade
- GO:0090090 negative regulation of canonical Wnt signaling pathway
- GO:0030336 negative regulation of cell migration
- GO:1904339 negative regulation of dopaminergic neuron differentiation
- GO:0010719 negative regulation of epithelial to mesenchymal transition
- GO:1902042 negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
- GO:0010629 negative regulation of gene expression
- GO:2000466 negative regulation of glycogen (starch) synthase activity
- GO:0045719 negative regulation of glycogen biosynthetic process
- GO:2000740 negative regulation of mesenchymal stem cell differentiation
- GO:0045668 negative regulation of osteoblast differentiation
- GO:1900181 negative regulation of protein localization to nucleus
- GO:0031333 negative regulation of protein-containing complex assembly
- GO:0032007 negative regulation of TOR signaling
- GO:1903940 negative regulation of TORC2 signaling
- GO:2000077 negative regulation of type B pancreatic cell development
- GO:0031175 neuron projection development
- GO:0106027 neuron projection organization
- GO:0018105 peptidyl-serine phosphorylation
- GO:0010508 positive regulation of autophagy
- GO:0045597 positive regulation of cell differentiation
- GO:0001954 positive regulation of cell-matrix adhesion
- GO:0045724 positive regulation of cilium assembly
- GO:0010628 positive regulation of gene expression
- GO:1901030 positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- GO:0043525 positive regulation of neuron apoptotic process
- GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- GO:0032092 positive regulation of protein binding
- GO:0045732 positive regulation of protein catabolic process
- GO:0046827 positive regulation of protein export from nucleus
- GO:1904781 positive regulation of protein localization to centrosome
- GO:1903566 positive regulation of protein localization to cilium
- GO:0031398 positive regulation of protein ubiquitination
- GO:0031334 positive regulation of protein-containing complex assembly
- GO:0032481 positive regulation of type I interferon production
- GO:0099171 presynaptic modulation of chemical synaptic transmission
- GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process
- GO:0046777 protein autophosphorylation
- GO:0006468 protein phosphorylation
- GO:0030516 regulation of axon extension
- GO:0050770 regulation of axonogenesis
- GO:1900034 regulation of cellular response to heat
- GO:0042752 regulation of circadian rhythm
- GO:0048814 regulation of dendrite morphogenesis
- GO:1900271 regulation of long-term synaptic potentiation
- GO:0150101 regulation of microtubule anchoring at centrosome
- GO:0070507 regulation of microtubule cytoskeleton organization
- GO:0032886 regulation of microtubule-based process
- GO:0010975 regulation of neuron projection development
- GO:0046825 regulation of protein export from nucleus
- GO:0034976 response to endoplasmic reticulum stress
- GO:0071109 superior temporal gyrus development
- GO:0019082 viral protein processing
- GO:0016055 Wnt signaling pathway
Drugs targeting this protein · 6
- LITHIUM CARBONATE inhibitor
- AZD-1080 inhibitor
- LITHIUM CITRATE inhibitor
- TIDEGLUSIB inhibitor
- LY-2090314 inhibitor
- ELRAGLUSIB inhibitor
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Glycogen synthase kinase-3 beta 1.00
- Glycogen synthase kinase-3 beta 1.00
- Glycogen synthase kinase-3 beta 1.00
- Glycogen synthase kinase-3 beta 0.99
- Shaggy-related protein kinase zeta 0.90
- Shaggy-related protein kinase GSK2 0.89
- Glycogen synthase kinase-3 0.89
- Glycogen synthase kinase-3 homolog MsK-2 0.89
- Glycogen synthase kinase-3 0.88
- Glycogen synthase kinase 1 0.88
- Shaggy-related protein kinase iota 0.88
- Shaggy-related protein kinase GSK4 0.88
Co-cited proteins · studied together in the literature
- Glycogen synthase kinase-3 alpha 10 shared papers
- GSK3B-interacting protein 4 shared papers
- Calcium-binding tyrosine phosphorylation-regulated protein 1 shared papers
- Proto-oncogene FRAT1 1 shared papers
- GSK3B-interacting protein 1 shared papers
- Palmitoyltransferase ZDHHC4 1 shared papers
- N-cym protein 1 shared papers
- Axin-1 3 shared papers
- Nucleoside diphosphate kinase 7 1 shared papers
- Serine/threonine-protein kinase SIK1 1 shared papers
- Exopolyphosphatase PRUNE1 1 shared papers
- Nuclear factor of activated T-cells, cytoplasmic 1 1 shared papers
Literature · 72 cited papers
- GSK3beta palmitoylation mediated by ZDHHC4 promotes tumorigenicity of glioblastoma stem cells in temozolomide-resistant glioblastoma through the EZH2-STAT3 axis. Oncogenesis · 2022
- The Protein Kinase Activity of NME7 Activates Wnt/beta-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma. Cancer Res. · 2022
- A catenin of the plakophilin-subfamily, Pkp3, responds to canonical-Wnt pathway components and signals. Biochem. Biophys. Res. Commun. · 2021
- LMBR1L regulates lymphopoiesis through Wnt/beta-catenin signaling. Science · 2019
- Pacer is a mediator of mTORC1 and GSK3-TIP60 signaling in regulation of autophagosome maturation and lipid metabolism. Mol. Cell · 2019
- SPSB3 targets SNAIL for degradation in GSK-3beta phosphorylation-dependent manner and regulates metastasis. Oncogene · 2018
- Phosphorylated E2F1 is stabilized by nuclear USP11 to drive Peg10 gene expression and activate lung epithelial cells. J. Mol. Cell Biol. · 2018
- Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating the stability and activity of BMAL1 and CLOCK. Oncotarget · 2017
- Twa1/Gid8 is a beta-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis. Cell Res. · 2017
- The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3beta Interaction Protein (GSKIP) Regulates beta-Catenin through Its Interactions with Both Protein Kinase A (PKA) and GSK3beta. J. Biol. Chem. · 2016
- GSKIP- and GSK3-mediated anchoring strengthens cAMP/PKA/Drp1 axis signaling in the regulation of mitochondrial elongation. Biochim. Biophys. Acta · 2015
- Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation. J. Biol. Chem. · 2015
- … and 60 more in the literature graph